Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessStemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and carries the worst prognosis, characterized by the lack of progesterone, estrogen, and HER2 gene expression. This study a...
-
Article
Open AccessProceedings of the 1st Liaquat University of Medical & Health Sciences (LUMHS) International Medical Research Conference